Categories: DataDrugPlatformTechnology
ReviveMed is a precision-medicine platform that leverages the data from small molecules or metabolites. ReviveMed technology, which was developed at MIT and published in Nature Methods, uniquely overcomes the difficulty of using a large set of metabolomic data, and transform these data into actionable insight. Currently, we selected a few strategic clients from leading pharma/biotech companies to provide them with drug de-risking, biomarker discovery and therapeutic solutions.
Investors 4
Funding Rounds 1
| Date | Series | Amount | Investors |
| 19.04.2018 | Seed | $1.5M | - |
Mentions in press and media 6
| Date | Title | Description | Source |
| 19.04.2018 | ReviveMed Raises $1.5M in Seed Funding | ReviveMed Inc., a Cambridge, MA-based developer of an AI-driven metabolomic platform for drug discov... | finsmes.co... |
| 18.04.2018 | ReviveMed turns drug discovery into a big data problem and r... | What if there’s a drug that already exists that could treat a disease with no known therapies, but w... | techcrunch... |
| 18.04.2018 | ReviveMed Raises $1.5M | CAMBRIDGE, Mass.--(BUSINESS WIRE)--ReviveMed Inc., today announced it has closed an oversubscribed s... | citybizlis... |
| 03.11.2017 | MassChallenge Boston Awards $1.5M in Equity-Free Prizes to T... | BOSTON - MassChallenge, the most startup-friendly accelerator on the planet, tonight awarded $1 mill... | masschalle... |
| 05.10.2017 | MassChallenge Boston Names Top 26 Startups | BOSTON, October 5, 2017 MassChallenge, the most startup-friendly accelerator on the planet, today an... | masschalle... |
| 23.05.2017 | MassChallenge Boston Announces 2017 Cohort | BOSTON, MAY 23, 2017 - MassChallenge, the most startup-friendly accelerator on the planet, today ann... | masschalle... |
Reviews 0
